Hossein Ardehali is a Cardiology physician affiliated with University of Arizona. OpenAlex indexes 243 publications with 9,668 citations (h-index 50).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3838 N Campbell Ave Bldg 2
Tucson, AZ 857191454
Telephone
520-694-3278Provider last certified this registry record 2 Dec 2025.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Hikma Pharmaceuticals USAProgram year20252 payments
- Novo Nordisk IncProgram year20241 payment
- Pharmacosmos Therapeutics Inc.Program year20234 payments$14,131openpaymentsdata.cms.gov ↗
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
95.8%Statin35.7%Atorvastatin Calcium86%Rosuvastatin Calcium14%Part D<11 patientsBeta blocker16.1%Metoprolol Succinate71%Carvedilol29%Part D<11 patients+ 7 more classes in this area
Blood & clotting
4.2%Factor Xa inhibitor4.2%Xarelto100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2025–2026 per NIH RePORTER. The latest:
- Hexokinase 1 mitochondrial binding and its role in cardiac endothelial cell function and the development of HFpEF
University of Arizona
FY2026$725,502R01HL175366 - Role of hexokinase 3 in macrophage polarization and cardiac remodeling after myocardial infraction.
University of Arizona
FY2026$667,337R01HL180711 - Small molecule therapeutics for heart failure through a reduction in the activity of tristetraprolin and improving cardiac metabolism.
University of Arizona
FY2026$562,733R61HL179722
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
Circulation Research
2023 - The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease
Nature Reviews Cardiology
2022 - Ironing out mechanisms of iron homeostasis and disorders of iron deficiency
Journal of Clinical Investigation
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Alpert, MD
University of Arizona
Lisa Rimsza, MD
University of Arizona
Karl Kern, MD
University of Arizona
Geoffrey Rubin, MD
University of Arizona
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”